Nuclear and mitochondrial compartmentation of oxidative stress and redox signaling

Annual Review of Pharmacology and Toxicology

Volumn 46, Issue , 2006, Pages 215-234

  Hansen, Jason M ^a   Go, Young Mi ^a   Jones, Dean P ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Glutathione; Green fluorescent protein; Redox Western analysis; Thioredoxin; Transcription factors

Indexed keywords

GREEN FLUORESCENT PROTEIN; TRANSCRIPTION FACTOR;

ALKALINITY; APOPTOSIS; CELL COMPARTMENTALIZATION; CELL NUCLEUS; CYTOPLASM; ENDOPLASMIC RETICULUM; EXTRACELLULAR SPACE; HUMAN; MITOCHONDRION; NECROSIS; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; TRANSCRIPTION INITIATION;

ANIMALS; CELL NUCLEUS; HUMANS; MITOCHONDRIA; OXIDATION-REDUCTION; OXIDATIVE STRESS; SIGNAL TRANSDUCTION;

EID: 33144490305     PISSN: 03621642     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pharmtox.46.120604.141122     Document Type: Review

References (105)

1. Sies H. 1985. Oxidative stress: introductory remarks. In Oxidative Stress, ed. H Sies, pp. 1-8. London: Academic
2. Jones DP. 2005. Redefining oxidative stress. Antioxid. Redox Signal. In press
3. Jones DP, Go YM, Anderson CL, Ziegler TR, Kinkade JM Jr, Kirlin WG. 2004. Cysteine/cystine couple is a newly recognized node in the circuitry for biologic redox signaling and control. FASEB J. 18:1246-48
4. Dijkwel PA, Wenink PW. 1986. Structural integrity of the nuclear matrix: differential effects of thiol agents and metal chelators. J. Cell Sci. 84:53-67
5. Klug A, Rhodes D. 1987. Zinc fingers: a novel protein fold for nucleic acid recognition. Cold Spring Harb. Symp. Quant. Biol. 52:473-82
6. De Capoa A, Ferraro M, Lavia P, Pelliccia F, Finazzi-Agro A. 1982. Silver staining of the nucleolus organizer regions (NOR) requires clusters of sulfhydryl groups. J. Histochem. Cytochem. 30:908-11
7. Suthanthiran M, Anderson ME, Sharma VK, Meister A. 1990. Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens. Proc. Natl. Acad. Sci. USA 87:3343-47
8. Sandstrom BE, Marklund SL. 1990. Effects of variation in glutathione peroxidase activity on DNA damage and cell survival in human cells exposed to hydrogen peroxide and t-butyl hydroperoxide. Biochem. J. 271:17-23
9. Sen CK, Packer L. 1996. Antioxidant and redox regulation of gene transcription. FASEB J. 10:709-20
10. Bellomo G, Palladini G, Vairetti M. 1997. Intranuclear distribution, function and fate of glutathione and glutathione-S-conjugate in living rat hepatocytes studied by fluorescence microscopy. Microsc. Res. Tech. 36:243-52
11. Bellomo G, Vairetti M, Stivala L, Mirabelli F, Richelmi P, Orrenius S. 1992. Demonstration of nuclear compartmentalization of glutathione in hepatocytes. Proc. Natl. Acad. Sci. USA 89:4412-16
12. Briviba K, Fraser G, Sies H, Ketterer B. 1993. Distribution of the monochlorobimane-glutathione conjugate between nucleus and cytosol in isolated hepatocytes. Biochem. J. 294 (Pt. 3):631-33
13. Jevtovic-Todorovic V, Guenthner TM. 1992. Depletion of a discrete nuclear glutathione pool by oxidative stress, but not by buthionine sulfoximine. Correlation with enhanced alkylating agent cytotoxicity to human melanoma cells in vitro. Biochem. Pharmacol. 44:1383-93
14. Voehringer DW, McConkey DJ, McDonnell TJ, Brisbay S, Meyn RE. 1998. Bcl-2 expression causes redistribution of glutathione to the nucleus. Proc. Natl. Acad. Sci. USA 95:2956-60
15. Cotgreave IA. 2003. Analytical developments in the assay of intra- and extracellular GSH homeostasis: specific protein S-glutathionylation, cellular GSH and mixed disulphide compartmentalisation and interstitial GSH redox balance. Biofactors 17:269-77
16. Woo HA, Chae HZ, Hwang SC, Yang KS, Kang SW, et al. 2003. Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation. Science 300:653-56
17. Kim JR, Lee SM, Cho SH, Kim JH, Kim BH, et al. 2004. Oxidation of thioredoxin reductase in HeLa cells stimulated with tumor necrosis factor-alpha. FEBS Lett. 567:189-96
18. Dooley CT, Dore TM, Hanson GT, Jackson WC, Remington SJ, Tsien RY. 2004. Imaging dynamic redox changes in mammalian cells with green fluorescent protein indicators. J. Biol. Chem. 279:22284-93
19. Wei SJ, Bolero A, Hirota K, Bradbury CM, Markovina S, et al. 2000. Thioredoxin nuclear translocation and interaction with redox factor-1 activates the activator protein-1 transcription factor in response to ionizing radiation. Cancer Res. 60:6688-95
20. Hirota K, Murata M, Sachi Y, Nakamura H, Takeuchi J, et al. 1999. Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB. J. Biol. Chem. 274:27891-97
21. Hirota K, Matsui M, Murata M, Takashima Y, Cheng FS, et al. 2000. Nucleoredoxin, glutaredoxin, and thioredoxin differentially regulate NF-kappaB, AP-1, and CREB activation in HEK293 cells. Biochem. Biophys. Res. Commun. 274:177-82
22. Halvey PJ, Watson WH, Hansen JM, Go YM, Samali A, Jones DP. 2005. Compartmental oxidation of thiol-disulphide redox couples during epidermal growth factor signalling. Biochem. J. 386:215-19
23. Watson WH, Pohl J, Montfort WR, Stuchlik O, Reed MS, et al. 2003. Redox potential of human thioredoxin 1 and identification of a second dithiol/disulfide motif. J. Biol. Chem. 278:33408-15
24. Holmgren A, Fagerstedt M. 1982. The in vivo distribution of oxidized and reduced thioredoxin in Escherichia coli. J. Biol. Chem. 257:6926-30
25. Watson WH, Jones DP. 2003. Oxidation of nuclear thioredoxin during oxidative stress. FEBS Lett. 543:144-47
26. Carpenter G, Cohen S. 1990. Epidermal growth factor. J. Biol Chem. 265:7709-12
27. 2 for platelet-derived growth factor signal transduction. Science 270:296-99
28. Abate C, Patel L, Rauscher FJ 3rd, Curran T. 1990. Redox regulation of fos and jun DNA-binding activity in vitro. Science 249:1157-61
29. Allen RG, Tresini M. 2000. Oxidative stress and gene regulation. Free Radic. Biol. Med. 28:463-99
30. Bloom D, Dhakshinamoorthy S, Jaiswal AK. 2002. Site-directed mutagenesis of cysteine to serine in the DNA binding region of Nrf2 decreases its capacity to upregulate antioxidant response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene. Oncogene 21:2191-200
31. Bodwell JE, Holbrook NJ, Munck A. 1984. Sulfhydryl-modifying reagents reversibly inhibit binding of glucocorticoid-receptor complexes to DNA-cellulose. Biochemistry 23:1392-98
32. Galter D, Mihm S, Droge W. 1994. Distinct effects of glutathione disulphide on the nuclear transcription factor kappa B and the activator protein-1. Eur. J. Biochem. 221:639-48
33. Hainaut P, Milner J. 1993. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res. 53:4469-73
34. Okamoto K, Tanaka H, Ogawa H, Makino Y, Eguchi H, et al. 1999. Redox-dependent regulation of nuclear import of the glucocorticoid receptor. J. Biol. Chem. 274:10363-71
35. Kudo N, Taoka H, Toda T, Yoshida M, Horinouchi S. 1999. A novel nuclear export signal sensitive to oxidative stress in the fission yeast transcription factor Pap1. J. Biol. Chem. 274:15151-58
36. Radler-Pohl A, Sachsenmaier C, Gebel S, Auer HP, Bruder JT, et al. 1993. UV-induced activation of AP-1 involves obligatory extranuclear steps including Raf-1 kinase. EMBO J. 12:1005-12
37. Devary Y, Gottlieb RA, Lau LF, Karin M. 1991. Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol. Cell. Biol. 11:2804-11
38. Cerutti PA, Trump BF. 1991. Inflammation and oxidative stress in carcinogenesis. Cancer Cells 3:1-7
39. Bauskin AR, Alkalay I, Ben-Neriah Y. 1991. Redox regulation of a protein tyrosine kinase in the endoplasmic reticulum. Cell 66:685-96
40. Abate C, Luk D, Gagne E, Roeder RG, Curran T. 1990. Fos and jun cooperate in transcriptional regulation via heterologous activation domains. Mol. Cell. Biol. 10:5532-35
41. Abate C, Curran T. 1990. Encounters with Fos and Jun on the road to AP-1. Semin. Cancer Biol. 1:19-26
42. Xanthoudakis S, Curran T. 1992. Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. EMBO J. 11:653-65
43. Hirota K, Matsui M, Iwata S, Nishiyama A, Mori K, Yodoi J. 1997. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc. Natl. Acad. Sci. USA 94:3633-38
44. Haddad JJ. 2002. Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors. Cell. Signal. 14:879-97
45. Sen R, Baltimore D. 1986. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell 47:921-28
46. Baeuerle PA, Henkel T. 1994. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12:141-79
47. Matthews JR, Kaszubska W, Turcatti G, Wells TN, Hay RT. 1993. Role of cysteine62 in DNA recognition by the P50 subunit of NF-kappa B. Nucleic Acids Res. 21:1727-34
48. Toledano MB, Leonard WJ. 1991. Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc. Natl. Acad. Sci. USA 88:4328-32
49. Toledano MB, Ghosh D, Trinh F, Leonard WJ. 1993. N-terminal DNA-binding domains contribute to differential DNA-binding specificities of NF-kappa B p50 and p65. Mol. Cell. Biol. 13:852-60
50. Kensler TW, Curphey TJ, Maxiutenko Y, Roebuck BD. 2000. Chemoprotection by organosulfur inducers of phase 2 enzymes: dithiolethiones and dithiins. Drug Metabol. Drug Interact. 17:3-22
51. Hansen JM, Watson WH, Jones DP. 2004. Compartmentation of Nrf-2 redox control: regulation of cytoplasmic activation by glutathione and DNA binding by thioredoxin-1. Toxicol. Sci. 82:308-17
52. Banmeyer I, Marchand C, Verhaeghe C, Vucic B, Rees JF, Knoops B. 2004. Overexpression of human peroxiredoxin 5 in subcellular compartments of Chinese hamster ovary cells: effects on cytotoxicity and DNA damage caused by peroxides. Free Radic. Biol. Med. 36:65-77
53. Rogers LK, Gupta S, Welty SE, Hansen TN, Smith CV. 2002. Nuclear and nucleolar glutathione reductase, peroxidase, and transferase activities in livers of male and female Fischer-344 rats. Toxicol. Sci. 69:279-85
54. Meredith MJ, Reed DJ. 1982. Status of the mitochondrial pool of glutathione in the isolated hepatocyte. J. Biol. Chem. 257:3747-53
55. Wahllander A, Soboll S, Sies H, Linke I, Muller M. 1979. Hepatic mitochondrial and cytosolic glutathione content and the subcellular distribution of GSH-S-transferases. FEBS Lett. 97:138-40
56. Jocelyn PC, Kamminga A. 1974. The non-protein thiol of rat liver mitochondria. Biochim. Biophys. Acta 343:356-62
57. Jocelyn PC. 1975. Some properties of mitochondrial glutathione. Biochim. Biophys. Acta 396:427-36
58. Vignais PM, Vignais PV. 1973. Fuscin, an inhibitor of mitochondrial SH-dependent transport-linked functions. Biochim. Biophys. Acta 325:357-74
59. Garcia-Ruiz C, Morales A, Ballesta A, Rodes J, Kaplowitz N, Fernandez-Checa JC. 1994. Effect of chronic ethanol feeding on glutathione and functional integrity of mitochondria in periportal and perivenous rat hepatocytes. J. Clin. Invest. 94:193-201
60. Shan X, Jones DP, Hashmi M, Anders MW. 1993. Selective depletion of mitochondrial glutathione concentrations by (R,S)-3-hydroxy-4-pentenoate potentiates oxidative cell death. Chem. Res. Toxicol. 6:75-81
61. Vendemiale G, Grattagliano I, Altomare E, Turturro N, Guerrieri F. 1996. Effect of acetaminophen administration on hepatic glutathione compartmentation and mitochondrial energy metabolism in the rat. Biochem. Pharmacol. 52:1147-54
62. Rebrin I, Sohal RS. 2004. Comparison of thiol redox state of mitochondria and homogenates of various tissues between two strains of mice with different longevities. Exp. Gerontol. 39:1513-19
63. Cai J, Jones DP. 1998. Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss. J. Biol. Chem. 273:11401-4
64. Sies H, Moss KM. 1978. A role of mitochondrial glutathione peroxidase in modulating mitochondrial oxidations in liver. Eur. J. Biochem. 84:377-83
65. Martensson J, Lai JC, Meister A. 1990. High-affinity transport of glutathione is part of a multicomponent system essential for mitochondrial function. Proc. Natl. Acad. Sci. USA 87:7185-89
66. Lash LH. 2005. Role of glutathione transport processes in kidney function. Toxicol. Appl. Pharmacol. 204:329-42
67. Lash LH, Putt DA, Matherly LH. 2002. Protection of NRK-52E cells, a rat renal proximal tubular cell line, from chemical-induced apoptosis by overexpression of a mitochondrial glutathione transporter. J. Pharmacol. Exp. Ther. 303:476-86
68. Chen Z, Lash LH. 1998. Evidence for mitochondrial uptake of glutathione by dicarboxylate and 2-oxoglutarate carriers. J. Pharmacol. Exp. Ther. 285:608-18
69. Chen Z, Putt DA, Lash LH. 2000. Enrichment and functional reconstitution of glutathione transport activity from rabbit kidney mitochondria: further evidence for the role of the dicarboxylate and 2-oxoglutarate carriers in mitochondrial glutathione transport. Arch. Biochem. Biophys. 373:193-202
70. Fernandez-Checa JC, Ookhtens M, Kaplowitz N. 1987. Effect of chronic ethanol feeding on rat hepatocytic glutathione. Compartmentation, efflux, and response to incubation with ethanol. J. Clin. Invest. 80:57-62
71. Fernandez-Checa JC, Ookhtens M, Kaplowitz N. 1989. Effects of chronic ethanol feeding on rat hepatocytic glutathione. Relationship of cytosolic glutathione to efflux and mitochondrial sequestration. J. Clin. Invest. 83:1247-52
72. Fernandez-Checa JC, Garcia-Ruiz C, Ookhtens M, Kaplowitz N. 1991. Impaired uptake of glutathione by hepatic mitochondria from chronic ethanol-fed rats. Tracer kinetic studies in vitro and in vivo and susceptibility to oxidant stress. J. Clin. Invest. 87:397-405
73. Lotscher HR, Winterhalter KH, Carafoli E, Richter C. 1980. The energy-state of mitochondria during the transport of Ca2+. Eur. J. Biochem. 110:211-16
74. Lehninger AL, Reynafarje B, Alexandre A, Villalobo A. 1980. Respiration-coupled H+ ejection by mitochondria. Ann. NY Acad. Sci. 341:585-92
75. Enoksson M, Fernandes AP, Prast S, Lillig CH, Holmgren A, Orrenius S. 2005. Overexpression of glutaredoxin 2 attenuates apoptosis by preventing cytochrome c release. Biochem. Biophys. Res. Commun. 327:774-79
76. Johansson C, Lillig CH, Holmgren A. 2004. Human mitochondrial glutaredoxin reduces S-glutathionylated proteins with high affinity accepting electrons from either glutathione or thioredoxin reductase. J. Biol. Chem. 279:7537-43
77. Beer SM, Taylor ER, Brown SE, Dahm CC, Costa NJ, et al. 2004. Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of mitochondrial membrane thiol proteins: implications for mitochondrial redox regulation and antioxidant DEFENSE. J. Biol. Chem. 279:47939-51
78. Damdimopoulos AE, Miranda-Vizuete A, Pelto-Huikko M, Gustafsson JA, Spyrou G. 2002. Human mitochondrial thioredoxin. Involvement in mitochondrial membrane potential and cell death. J. Biol. Chem. 277:33249-57
79. Yodoi J. 2000. Evolution of thioredoxin and redox signaling research: viewpoint. Antioxid. Redox Signal. 2:629-30
80. Chen Y, Cai J, Murphy TJ, Jones DP. 2002. Overexpressed human mitochondrial thioredoxin confers resistance to oxidant-induced apoptosis in human osteosarcoma cells. J. Biol. Chem. 277:33242-48
81. Nonn L, Berggren M, Powis G. 2003. Increased expression of mitochondrial peroxiredoxin-3 (thioredoxin peroxidase-2) protects cancer cells against hypoxia and drug-induced hydrogen peroxide-dependent apoptosis. Mol. Cancer Res. 1:682-89
82. Patenaude A, Ven Murthy MR, Mirault ME. 2004. Mitochondrial thioredoxin system: effects of TrxR2 overexpression on redox balance, cell growth, and apoptosis. J. Biol. Chem. 279:27302-14
83. Zhang R, Al-Lamki R, Bai L, Streb JW, Miano JM, et al. 2004. Thioredoxin-2 inhibits mitochondria-located ASK1-mediated apoptosis in a JNK-independent manner. Circ. Res. 94:1483-91
84. Hanson GT, Aggeler R, Oglesbee D, Cannon M, Capaldi RA, et al. 2004. Investigating mitochondrial redox potential with redox-sensitive green fluorescent protein indicators. J. Biol. Chem. 279:13044-53
85. Moriarty-Craige SE, Jones DP. 2004. Extracellular thiols and thiol/disulfide redox in metabolism. Annu. Rev. Nutr. 24:481-509
86. Jones DP, Mody VC Jr, Carlson JL, Lynn MJ, Sternberg P Jr. 2002. Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses. Free Radic. Biol. Med. 33:1290-300
87. Moriarty SE, Shah JH, Lynn M, Jiang S, Openo K, et al. 2003. Oxidation of glutathione and cysteine in human plasma associated with smoking. Free Radic. Biol. Med. 35:1582-88
88. Jonas CR, Puckett AB, Jones DP, Griffith DP, Szeszycki EE, et al. 2000. Plasma antioxidant status after high-dose chemotherapy: a randomized trial of parenteral nutrition in bone marrow transplantation patients. Am. J. Clin. Nutr. 72:181-89
89. Samiec PS, Drews-Botsch C, Flagg EW, Kurtz JC, Sternberg P Jr, et al. 1998. Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. Free Radic. Biol. Med. 24:699-704
90. Abramson JL, Hooper WC, Jones DP, Ashfaq S, Rhodes SD, et al. 2005. Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease. Atherosclerosis 178:115-21
91. Jonas CR, Ziegler TR, Gu LH, Jones DP. 2002. Extracellular thiol/disulfide redox state affects proliferation rate in a human colon carcinoma (Caco2) cell line. Free Radic. Biol. Med. 33:1499-506
92. Go Y-M, Jones DP. 2005. Intracellular proatherogenic events and cell adhesion modulated by extracellular thiol/disulfide redox state. Circulation 111:2973-80
93. Kinscherf R, Cafaltzis K, Roder F, Hildebrandt W, Edler L, et al. 2003. Cholesterol levels linked to abnormal plasma thiol concentrations and thiol/disulfide redox status in hyperlipidernic subjects. Free Radic. Biol. Med. 35:1286-92
94. Di Giuseppe D, Frosali S, Priora R, Di Simplicio FC, Buonocore G, et al. 2004. The effects of age and hyperhomocysteinemia on the redox forms of plasma thiols. J. Lab. Clin. Med. 144:235-45
95. Hwang C, Sinskey AJ. 1991. Production of Biologicals from Animal Cells in Culture, ed. RE Spier, JB Griffiths, B Meignier, pp. 548-67. Oxford: Halley Court
96. Jones DP. 2002. Redox potential of GSH/GSSG couple: assay and biological significance. Methods Enzymol. 348:93-112
97. Jiang SM, Miller SE, Jones DP, Sternberg P Jr. 2001. Regulations of human retinal pigment epithelial (hRPE) cell growth and cellular glutathione/ glutathione disulfide (GSH/GSSG) redox status by changing extracellular cysteine/cystine (Cys/CySS). Invest. Ophthalmol. Vis. Sci. 42:B75
98. Jiang S, Moriarty SE, Grossniklaus H, Nelson KC, Jones DP, Sternberg P Jr. 2002. Increased oxidant-induced apoptosis in cultured nondividing human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 43:2546-53
99. Nelson KC, Armstrong JS, Moriarty S, Cai J, Wu MW, et al. 2002. Protection of retinal pigment epithelial cells from oxidative damage by oltipraz, a cancer chemopreventive agent. Invest. Ophthalmol. Vis. Sci. 43:3550-54
100. Jiang S, Moriarry-Craige SE, Orr M, Cai J, Sternberg P Jr, Jones DP. 2005. Oxidant-induced apoptosis in human retinal pigment epithelial cells: dependence on extracellular redox state. Invest. Ophthalmol. Vis. Sci. 46:1054-61
101. Nkabyo YS, Go YM, Ziegler TR, Jones DP. 2005. Extracellular cysteine/cystine redox regulates the p44/42 MAPK pathway by metalloproteinase- dependent epidermal growth factor receptor (EGFR) signaling. Am. J. Physiol. Gastrointest. Liver Physiol. 289:G70-78
102. Jones DP, Aw TY, Sillau AH. 1990. Defining the resistance to oxygen transfer in tissue hypoxia. Experientia 46:1180-85
103. Ohlendieck K, Partin JS, Lennarz WJ. 1994. The biologically active form of the sea urchin egg receptor for sperm is a disulfide-bonded homo-multimer. J. Cell Biol. 125:817-24
104. Rancourt RC, Tai S, King M, Heltshe SL, Penvari C, et al. 2004. Thioredoxin liquefies and decreases the viscoelasticity of cystic fibrosis sputum. Am. J. Physiol. Lung Cell Mol. Physiol. 286:L931-38
105. Hwang C, Sinskey AJ, Lodish HF. 1992. Oxidized redox state of glutathione in the endoplasmic reticulum. Science 257:1496-502